• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Del expands into R/F with Acoma buy

Article

X-ray vendor Del Global Technologies has expanded into radiography/fluoroscopy by acquiring the assets of Acoma Medical Imaging on Nov. 30. The acquisition will make Del's products more attractive to OEMs because it broadens the line.Acoma of Wheeling,

X-ray vendor Del Global Technologies has expanded into radiography/fluoroscopy by acquiring the assets of Acoma Medical Imaging on Nov. 30. The acquisition will make Del's products more attractive to OEMs because it broadens the line.

Acoma of Wheeling, IL, was owned by Acoma Medical Industry of Japan and was one of the smaller players in the R/F market, selling low-cost systems. Acoma's products fit well with Del's line of cost-effective radiography systems, according to Leonard Trugman, CEO and president of Del.

The company will probably close Acoma's Wheeling plant, although it plans to retain Acoma engineers and executives to help Del develop new products. Del is looking for additional acquisitions, especially in Europe and Asia, Trugman said.

In other Del news, the company's Gendex-Del subsidiary won a five-year contract worth $10 million from a national medical equipment buying group. Deliveries are scheduled to begin in the spring.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.